Waldenström Macroglobulinemia is a rare type of non-Hodgkin lymphoma affecting B-cells. Waldenström Macroglobulinemia is characterised by high levels of circulating antibodies, immunoglobulin M, which is made and secreted by the cells involved in the disease. It is usually an indolent disease with no or limited symptoms. Therefore, patients with Waldenström Macroglobulinemia are often follow closely in “Watchful Waiting” until the disease and symptoms require onset of treatment.
Our guest Ida Bruun Kristensen, haematologist at Odense University Hospital. Ida is an active member in both the Danish Lymphoma Group and Danish Myeloma Study Group as the active in the Nordic clinical societies and is responsible for several ongoing clinical studies. In this episode of our Haematology Podcast Ida enlighten us on Waldenström Macroglobulinemia, its clinical implications and treatment options for the patients today and in the future.
